

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57091777 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.57091777 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25214069 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25214069 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.84535926 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.45758126 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.21135513 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.21135513 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.21135513 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.07430989 |
| 11 | regulation of plasminogen activation (GO:0010755) | 5.98414296 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.96799728 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.84341034 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.74988851 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.72154964 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.71135214 |
| 17 | urea cycle (GO:0000050) | 5.70306723 |
| 18 | urea metabolic process (GO:0019627) | 5.70306723 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54303330 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.49436241 |
| 21 | protein carboxylation (GO:0018214) | 5.46373309 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.46373309 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.36774213 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.35464886 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 5.35218738 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.33015079 |
| 27 | cysteine metabolic process (GO:0006534) | 5.31681066 |
| 28 | intestinal cholesterol absorption (GO:0030299) | 5.30825345 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.24218989 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.14093508 |
| 31 | bile acid metabolic process (GO:0008206) | 5.10333148 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 5.07545451 |
| 33 | acute-phase response (GO:0006953) | 5.05535437 |
| 34 | exogenous drug catabolic process (GO:0042738) | 5.02462257 |
| 35 | regulation of complement activation (GO:0030449) | 4.99178485 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.98083536 |
| 37 | negative regulation of protein activation cascade (GO:2000258) | 4.95995452 |
| 38 | regulation of apoptotic cell clearance (GO:2000425) | 4.95858140 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.94502980 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.88232539 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.88232539 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.88232539 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.86978740 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85949211 |
| 45 | protein-lipid complex subunit organization (GO:0071825) | 4.83936455 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.81369097 |
| 47 | regulation of humoral immune response (GO:0002920) | 4.81289435 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.78292335 |
| 49 | negative regulation of hemostasis (GO:1900047) | 4.78292335 |
| 50 | phospholipid efflux (GO:0033700) | 4.72078758 |
| 51 | omega-hydroxylase P450 pathway (GO:0097267) | 4.72012229 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.70921134 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.69441955 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.69441955 |
| 55 | positive regulation of hemostasis (GO:1900048) | 4.67639815 |
| 56 | positive regulation of blood coagulation (GO:0030194) | 4.67639815 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.63847427 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.63689137 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.63689137 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 4.57198411 |
| 61 | lysine catabolic process (GO:0006554) | 4.54405846 |
| 62 | lysine metabolic process (GO:0006553) | 4.54405846 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.49599494 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.43262340 |
| 65 | glycine metabolic process (GO:0006544) | 4.42375684 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.39912207 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.39695612 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.37976034 |
| 69 | negative regulation of coagulation (GO:0050819) | 4.36994119 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.35378582 |
| 71 | cholesterol efflux (GO:0033344) | 4.31782139 |
| 72 | amine catabolic process (GO:0009310) | 4.31399713 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.31399713 |
| 74 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.30475822 |
| 75 | positive regulation of coagulation (GO:0050820) | 4.28361479 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.25851870 |
| 77 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.25823694 |
| 78 | cellular glucuronidation (GO:0052695) | 4.24292339 |
| 79 | negative regulation of wound healing (GO:0061045) | 4.22773115 |
| 80 | glutamate metabolic process (GO:0006536) | 4.21354586 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.16490012 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.15958102 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 4.09947700 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.09514724 |
| 85 | negative regulation of complement activation (GO:0045916) | 4.06865328 |
| 86 | fibrinolysis (GO:0042730) | 4.06817524 |
| 87 | ethanol oxidation (GO:0006069) | 4.06502186 |
| 88 | arginine metabolic process (GO:0006525) | 4.05030298 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02782435 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 4.02775116 |
| 91 | aldehyde catabolic process (GO:0046185) | 4.00947223 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 4.00126504 |
| 93 | ethanol metabolic process (GO:0006067) | 3.99618248 |
| 94 | drug catabolic process (GO:0042737) | 3.95288692 |
| 95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.89633222 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.85363668 |
| 97 | ketone body metabolic process (GO:1902224) | 3.83507831 |
| 98 | cofactor catabolic process (GO:0051187) | 3.82439635 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82435330 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82435330 |
| 101 | lipoprotein metabolic process (GO:0042157) | 3.82310576 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.81950465 |
| 103 | acute inflammatory response (GO:0002526) | 3.81880770 |
| 104 | complement activation, classical pathway (GO:0006958) | 3.80046751 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.78697863 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.76350521 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.76350521 |
| 108 | proline metabolic process (GO:0006560) | 3.76274380 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.75547647 |
| 110 | complement activation (GO:0006956) | 3.75477283 |
| 111 | protein activation cascade (GO:0072376) | 3.75048327 |
| 112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71704841 |
| 113 | organic acid catabolic process (GO:0016054) | 3.71634265 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.71634265 |
| 115 | phospholipid homeostasis (GO:0055091) | 3.71251654 |
| 116 | plasma lipoprotein particle organization (GO:0071827) | 3.70440978 |
| 117 | sterol homeostasis (GO:0055092) | 3.69318585 |
| 118 | drug metabolic process (GO:0017144) | 3.68748382 |
| 119 | protein-lipid complex assembly (GO:0065005) | 3.68226433 |
| 120 | cytolysis (GO:0019835) | 3.66069658 |
| 121 | sterol transport (GO:0015918) | 3.64839875 |
| 122 | cholesterol transport (GO:0030301) | 3.64839875 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.64540519 |
| 124 | acetyl-CoA metabolic process (GO:0006084) | 3.63241259 |
| 125 | regulation of cholesterol homeostasis (GO:2000188) | 3.61210873 |
| 126 | heme transport (GO:0015886) | 3.61012922 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.60741785 |
| 128 | positive regulation of extracellular matrix organization (GO:1903055) | 3.58572705 |
| 129 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.53244777 |
| 130 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.53244777 |
| 131 | regulation of lipoprotein particle clearance (GO:0010984) | 3.48167939 |
| 132 | phenylpropanoid metabolic process (GO:0009698) | 3.47084510 |
| 133 | opsonization (GO:0008228) | 3.44938466 |
| 134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.41550082 |
| 135 | oxidative demethylation (GO:0070989) | 3.36898143 |
| 136 | positive regulation of steroid metabolic process (GO:0045940) | 3.36714828 |
| 137 | regulation of acute inflammatory response (GO:0002673) | 3.33455423 |
| 138 | intestinal absorption (GO:0050892) | 3.32726371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40817470 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21245664 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.11001443 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51959100 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32208616 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17963136 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88475223 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06226420 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04092637 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06514670 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9416723 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98744952 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97460482 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.91345171 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60241201 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51534622 |
| 17 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45929126 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39987625 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37786686 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22051704 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21767421 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21426656 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08699536 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07954189 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06281810 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01966138 |
| 27 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01787274 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01412931 |
| 29 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99000316 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97332198 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95307467 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94636178 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94103351 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.91652659 |
| 35 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90682216 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90482363 |
| 37 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89982888 |
| 38 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88226567 |
| 39 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85185899 |
| 40 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84316042 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83937892 |
| 42 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83854650 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82943869 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82795037 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82493750 |
| 46 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80344684 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80036806 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79549059 |
| 49 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.78090571 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77984211 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77329080 |
| 52 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77224940 |
| 53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75324129 |
| 54 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75131612 |
| 55 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73878997 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73368882 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72639849 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.72011249 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71798147 |
| 60 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.71476503 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.70243382 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68309924 |
| 63 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.68165528 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68016216 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67810160 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67029665 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66773982 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66723608 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66334312 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65473373 |
| 71 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.65128114 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64523527 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64233048 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64172720 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63666994 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63666994 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62490383 |
| 78 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62107724 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.62103785 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.61960440 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.61809498 |
| 82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61548475 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61538574 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61262877 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60695669 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60626811 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.60443948 |
| 88 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.58935949 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58095890 |
| 90 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.57241443 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.57105571 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 0.57064520 |
| 93 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.56841215 |
| 94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54934014 |
| 95 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.54870880 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.54160279 |
| 97 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.54027833 |
| 98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53607791 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52971169 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52610036 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51987759 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51930705 |
| 103 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51547077 |
| 104 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50271219 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50122229 |
| 106 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49666538 |
| 107 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49088832 |
| 108 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.48331682 |
| 109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47103212 |
| 110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46579272 |
| 111 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46511182 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43590998 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43259363 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42862946 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.42519727 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41560243 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41031943 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40898751 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.40738722 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40669747 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40474523 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39285758 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39022715 |
| 124 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38974390 |
| 125 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38866727 |
| 126 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38844941 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38202549 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37841667 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37533405 |
| 130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36445057 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36039328 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.35944535 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35296579 |
| 134 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35020094 |
| 135 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34825369 |
| 136 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33938243 |
| 137 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.33176522 |
| 138 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32851398 |
| 139 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32544343 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32468378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.38498222 |
| 2 | MP0005360_urolithiasis | 7.55076150 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44137447 |
| 4 | MP0005365_abnormal_bile_salt | 6.20815986 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.12415866 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26193617 |
| 7 | MP0003252_abnormal_bile_duct | 3.87999480 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60574694 |
| 9 | MP0009840_abnormal_foam_cell | 3.39414575 |
| 10 | MP0005083_abnormal_biliary_tract | 3.03235664 |
| 11 | MP0003195_calcinosis | 2.85661791 |
| 12 | MP0005332_abnormal_amino_acid | 2.75443441 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58314693 |
| 14 | MP0003122_maternal_imprinting | 2.46130953 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.34581828 |
| 16 | MP0000609_abnormal_liver_physiology | 2.17016415 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.10764206 |
| 18 | * MP0002118_abnormal_lipid_homeostasis | 2.07011964 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.98187841 |
| 20 | MP0003868_abnormal_feces_composition | 1.89085292 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.82938050 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.64636243 |
| 23 | MP0009697_abnormal_copulation | 1.64135458 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55892864 |
| 25 | MP0001915_intracranial_hemorrhage | 1.55537883 |
| 26 | MP0005451_abnormal_body_composition | 1.47993658 |
| 27 | * MP0001764_abnormal_homeostasis | 1.42963886 |
| 28 | MP0000566_synostosis | 1.42421744 |
| 29 | MP0003011_delayed_dark_adaptation | 1.37880894 |
| 30 | MP0002089_abnormal_postnatal_growth/wei | 1.34096374 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.28241611 |
| 32 | MP0003186_abnormal_redox_activity | 1.27908205 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.22532078 |
| 34 | MP0000598_abnormal_liver_morphology | 1.17769747 |
| 35 | MP0005647_abnormal_sex_gland | 1.15547606 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.15272946 |
| 37 | MP0000604_amyloidosis | 1.12139116 |
| 38 | MP0009764_decreased_sensitivity_to | 1.09019481 |
| 39 | MP0003123_paternal_imprinting | 1.05823629 |
| 40 | MP0002254_reproductive_system_inflammat | 1.01608176 |
| 41 | * MP0009763_increased_sensitivity_to | 0.98980072 |
| 42 | MP0010368_abnormal_lymphatic_system | 0.95646338 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.93222470 |
| 44 | MP0008469_abnormal_protein_level | 0.91849736 |
| 45 | * MP0009642_abnormal_blood_homeostasis | 0.86658808 |
| 46 | MP0005408_hypopigmentation | 0.86255544 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 0.84069381 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.81444915 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.78423409 |
| 50 | MP0003879_abnormal_hair_cell | 0.77473331 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.76651747 |
| 52 | MP0005670_abnormal_white_adipose | 0.76617513 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.75911512 |
| 54 | MP0002876_abnormal_thyroid_physiology | 0.75696481 |
| 55 | * MP0005376_homeostasis/metabolism_phenot | 0.73523698 |
| 56 | MP0002971_abnormal_brown_adipose | 0.72056090 |
| 57 | MP0003690_abnormal_glial_cell | 0.70873864 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.69753161 |
| 59 | MP0009785_altered_susceptibility_to | 0.68873295 |
| 60 | MP0005334_abnormal_fat_pad | 0.68629253 |
| 61 | MP0004130_abnormal_muscle_cell | 0.67363462 |
| 62 | MP0009053_abnormal_anal_canal | 0.67140084 |
| 63 | MP0001661_extended_life_span | 0.66054289 |
| 64 | MP0003329_amyloid_beta_deposits | 0.65881779 |
| 65 | MP0005535_abnormal_body_temperature | 0.65743415 |
| 66 | MP0005409_darkened_coat_color | 0.64911522 |
| 67 | MP0005266_abnormal_metabolism | 0.64330604 |
| 68 | MP0000639_abnormal_adrenal_gland | 0.61913346 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.61320944 |
| 70 | MP0000858_altered_metastatic_potential | 0.60205888 |
| 71 | MP0001756_abnormal_urination | 0.58008446 |
| 72 | MP0005464_abnormal_platelet_physiology | 0.57079215 |
| 73 | MP0006054_spinal_hemorrhage | 0.56114164 |
| 74 | MP0003878_abnormal_ear_physiology | 0.54679327 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.54679327 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.54417369 |
| 77 | MP0005448_abnormal_energy_balance | 0.54106770 |
| 78 | MP0003718_maternal_effect | 0.52776087 |
| 79 | MP0005395_other_phenotype | 0.51522869 |
| 80 | MP0002282_abnormal_trachea_morphology | 0.51439252 |
| 81 | MP0008260_abnormal_autophagy | 0.49843195 |
| 82 | MP0002933_joint_inflammation | 0.49397136 |
| 83 | MP0002419_abnormal_innate_immunity | 0.49027427 |
| 84 | MP0000920_abnormal_myelination | 0.48595303 |
| 85 | MP0000685_abnormal_immune_system | 0.47745721 |
| 86 | MP0002822_catalepsy | 0.47450239 |
| 87 | MP0003436_decreased_susceptibility_to | 0.47355125 |
| 88 | MP0008874_decreased_physiological_sensi | 0.46536309 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.45806917 |
| 90 | MP0008873_increased_physiological_sensi | 0.45438457 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.45184419 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.44698038 |
| 93 | MP0005023_abnormal_wound_healing | 0.44441038 |
| 94 | MP0003724_increased_susceptibility_to | 0.43688028 |
| 95 | MP0002928_abnormal_bile_duct | 0.43082622 |
| 96 | MP0003075_altered_response_to | 0.42801208 |
| 97 | MP0004272_abnormal_basement_membrane | 0.41132833 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.40726290 |
| 99 | MP0005166_decreased_susceptibility_to | 0.40444651 |
| 100 | MP0003567_abnormal_fetal_cardiomyocyte | 0.40088089 |
| 101 | MP0003953_abnormal_hormone_level | 0.39760284 |
| 102 | MP0009333_abnormal_splenocyte_physiolog | 0.38955973 |
| 103 | MP0003632_abnormal_nervous_system | 0.38699955 |
| 104 | * MP0005025_abnormal_response_to | 0.38390610 |
| 105 | MP0003303_peritoneal_inflammation | 0.38294691 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 0.38228768 |
| 107 | MP0006082_CNS_inflammation | 0.37655639 |
| 108 | MP0004381_abnormal_hair_follicle | 0.37566315 |
| 109 | MP0008872_abnormal_physiological_respon | 0.36984563 |
| 110 | MP0003121_genomic_imprinting | 0.36927663 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.36074952 |
| 112 | MP0000579_abnormal_nail_morphology | 0.35569094 |
| 113 | MP0005257_abnormal_intraocular_pressure | 0.35426478 |
| 114 | MP0009672_abnormal_birth_weight | 0.35421103 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.35127655 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.35003160 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.34676783 |
| 118 | MP0005076_abnormal_cell_differentiation | 0.34516711 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.34330396 |
| 120 | MP0000249_abnormal_blood_vessel | 0.33626547 |
| 121 | MP0009115_abnormal_fat_cell | 0.33585616 |
| 122 | MP0004883_abnormal_blood_vessel | 0.32995910 |
| 123 | MP0001324_abnormal_eye_pigmentation | 0.32632884 |
| 124 | MP0001853_heart_inflammation | 0.31966518 |
| 125 | MP0001243_abnormal_dermal_layer | 0.31488234 |
| 126 | MP0002168_other_aberrant_phenotype | 0.31245247 |
| 127 | MP0002796_impaired_skin_barrier | 0.30702781 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.30312248 |
| 129 | MP0002970_abnormal_white_adipose | 0.29976080 |
| 130 | MP0001881_abnormal_mammary_gland | 0.29361201 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.29140412 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.27079755 |
| 133 | MP0002132_abnormal_respiratory_system | 0.26385227 |
| 134 | MP0005164_abnormal_response_to | 0.26107290 |
| 135 | MP0005058_abnormal_lysosome_morphology | 0.26096890 |
| 136 | MP0002090_abnormal_vision | 0.22637745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.49396359 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42457294 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.31157435 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.70842479 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.66313284 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46950819 |
| 7 | Xanthomatosis (HP:0000991) | 6.29183211 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.62916282 |
| 9 | Complement deficiency (HP:0004431) | 5.41939278 |
| 10 | Joint hemorrhage (HP:0005261) | 4.90722117 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.84214838 |
| 12 | Hyperammonemia (HP:0001987) | 4.59372267 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.49793622 |
| 14 | Epidermoid cyst (HP:0200040) | 4.47127599 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42350758 |
| 16 | Hyperglycinemia (HP:0002154) | 4.41910566 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.28519644 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24468220 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.23352955 |
| 20 | Ketosis (HP:0001946) | 4.22260312 |
| 21 | Fat malabsorption (HP:0002630) | 4.13953492 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09167348 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08692667 |
| 24 | Abnormality of complement system (HP:0005339) | 3.96687364 |
| 25 | Hyperglycinuria (HP:0003108) | 3.89816981 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.88542695 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88216545 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.88216545 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.85950092 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79826324 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69081447 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.65496390 |
| 33 | Purpura (HP:0000979) | 3.51481147 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34882891 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.32820921 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31610779 |
| 37 | Steatorrhea (HP:0002570) | 3.14882328 |
| 38 | Spontaneous abortion (HP:0005268) | 3.10160995 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.07731176 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06703848 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.06021116 |
| 42 | Myocardial infarction (HP:0001658) | 3.01723995 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 3.01590146 |
| 44 | Ketoacidosis (HP:0001993) | 2.97609180 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.96191862 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.81329968 |
| 47 | Skin nodule (HP:0200036) | 2.75953543 |
| 48 | Metabolic acidosis (HP:0001942) | 2.73519347 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.65784425 |
| 50 | Vascular calcification (HP:0004934) | 2.60712653 |
| 51 | Lethargy (HP:0001254) | 2.59863579 |
| 52 | Pulmonary embolism (HP:0002204) | 2.55369292 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.54483279 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54483279 |
| 55 | Glomerulonephritis (HP:0000099) | 2.52814038 |
| 56 | Acanthocytosis (HP:0001927) | 2.52479436 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.47902072 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.47844152 |
| 59 | Osteomalacia (HP:0002749) | 2.46921288 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.46381992 |
| 61 | Mitral stenosis (HP:0001718) | 2.44988475 |
| 62 | Spastic diplegia (HP:0001264) | 2.44079675 |
| 63 | Abnormality of carpal bone ossification (HP:0006257) | 2.41112130 |
| 64 | Cerebral edema (HP:0002181) | 2.40747153 |
| 65 | Cholelithiasis (HP:0001081) | 2.40732335 |
| 66 | Gout (HP:0001997) | 2.38205636 |
| 67 | Amyloidosis (HP:0011034) | 2.36083727 |
| 68 | Irritability (HP:0000737) | 2.35266725 |
| 69 | Neonatal onset (HP:0003623) | 2.34187954 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.33334297 |
| 71 | Cholecystitis (HP:0001082) | 2.33334297 |
| 72 | Abnormal tarsal ossification (HP:0008369) | 2.31985613 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.30801380 |
| 74 | Gingival bleeding (HP:0000225) | 2.28977426 |
| 75 | Arthropathy (HP:0003040) | 2.26905695 |
| 76 | Malnutrition (HP:0004395) | 2.25218438 |
| 77 | Esophageal varix (HP:0002040) | 2.22289211 |
| 78 | Menorrhagia (HP:0000132) | 2.19291305 |
| 79 | Epistaxis (HP:0000421) | 2.17470187 |
| 80 | Late onset (HP:0003584) | 2.15432154 |
| 81 | Pancreatitis (HP:0001733) | 2.13620754 |
| 82 | Brushfield spots (HP:0001088) | 2.13060656 |
| 83 | Thrombophlebitis (HP:0004418) | 2.12566920 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.12292593 |
| 85 | Enlarged kidneys (HP:0000105) | 2.05902376 |
| 86 | Vomiting (HP:0002013) | 2.04865503 |
| 87 | Gangrene (HP:0100758) | 2.03825273 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.02929161 |
| 89 | Opisthotonus (HP:0002179) | 2.02682481 |
| 90 | Poikilocytosis (HP:0004447) | 2.01956063 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.00859978 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 2.00531185 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00354464 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 1.99579866 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.99061642 |
| 96 | Facial shape deformation (HP:0011334) | 1.97910012 |
| 97 | Potter facies (HP:0002009) | 1.97910012 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94352663 |
| 99 | Increased serum ferritin (HP:0003281) | 1.93699558 |
| 100 | Rickets (HP:0002748) | 1.91933528 |
| 101 | Increased serum pyruvate (HP:0003542) | 1.91709493 |
| 102 | Joint swelling (HP:0001386) | 1.89333192 |
| 103 | Flat acetabular roof (HP:0003180) | 1.88934830 |
| 104 | Hypophosphatemic rickets (HP:0004912) | 1.87370192 |
| 105 | Abnormality of the lumbar spine (HP:0100712) | 1.86398519 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 1.85234225 |
| 107 | Renal cortical cysts (HP:0000803) | 1.82311038 |
| 108 | Broad alveolar ridges (HP:0000187) | 1.81731760 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.80994746 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 1.80994746 |
| 111 | Nephritis (HP:0000123) | 1.79776542 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79646559 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.79645310 |
| 114 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78303223 |
| 115 | Status epilepticus (HP:0002133) | 1.77960131 |
| 116 | Alkalosis (HP:0001948) | 1.76852605 |
| 117 | Hyperglycemia (HP:0003074) | 1.76529290 |
| 118 | Abnormal ossification of hand bones (HP:0005921) | 1.75104933 |
| 119 | Abnormal hand bone ossification (HP:0010660) | 1.73603307 |
| 120 | Peritonitis (HP:0002586) | 1.73550216 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.71539881 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71539881 |
| 123 | Abnormality of vitamin metabolism (HP:0100508) | 1.70971615 |
| 124 | Small epiphyses (HP:0010585) | 1.70422497 |
| 125 | Vaginal fistula (HP:0004320) | 1.70207042 |
| 126 | Bifid scrotum (HP:0000048) | 1.69679126 |
| 127 | Abnormality of glycolysis (HP:0004366) | 1.68674528 |
| 128 | Hypochromic anemia (HP:0001931) | 1.68054734 |
| 129 | Widely patent fontanelles and sutures (HP:0004492) | 1.66366630 |
| 130 | Reduced antithrombin III activity (HP:0001976) | 1.65308540 |
| 131 | Gastrointestinal infarctions (HP:0005244) | 1.64555912 |
| 132 | Asymmetry of the thorax (HP:0001555) | 1.63501605 |
| 133 | Prolonged bleeding time (HP:0003010) | 1.56461097 |
| 134 | Optic neuritis (HP:0100653) | 1.56451682 |
| 135 | Retrobulbar optic neuritis (HP:0100654) | 1.56451682 |
| 136 | Abnormal delivery (HP:0001787) | 1.55996725 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.55935129 |
| 138 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.55935129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.17188527 |
| 2 | FGFR4 | 4.67492999 |
| 3 | SIK1 | 4.56494317 |
| 4 | ERN1 | 4.35059734 |
| 5 | TAOK3 | 3.29219182 |
| 6 | ERBB4 | 2.98368895 |
| 7 | INSRR | 2.83128111 |
| 8 | CDK12 | 2.53268871 |
| 9 | MAP2K4 | 2.32747946 |
| 10 | WNK4 | 2.27784047 |
| 11 | PKN2 | 2.18044402 |
| 12 | MST1R | 2.06504489 |
| 13 | FLT3 | 1.89689104 |
| 14 | PIK3CG | 1.89190992 |
| 15 | MAPK11 | 1.87394501 |
| 16 | TYRO3 | 1.85763714 |
| 17 | TRIB3 | 1.81477470 |
| 18 | TYK2 | 1.80716953 |
| 19 | DAPK2 | 1.67152144 |
| 20 | FGFR1 | 1.66912640 |
| 21 | LATS1 | 1.66882272 |
| 22 | ABL2 | 1.56526094 |
| 23 | NEK9 | 1.45025590 |
| 24 | SIK2 | 1.44362281 |
| 25 | PTK6 | 1.43991560 |
| 26 | PDGFRA | 1.41544789 |
| 27 | FGR | 1.34036442 |
| 28 | JAK2 | 1.28241913 |
| 29 | KDR | 1.27915973 |
| 30 | FGFR2 | 1.25970770 |
| 31 | FRK | 1.24571254 |
| 32 | TBK1 | 1.15943912 |
| 33 | PINK1 | 1.12050389 |
| 34 | MAP3K2 | 1.10469442 |
| 35 | MAP3K7 | 1.10262742 |
| 36 | PRKAA2 | 1.09713223 |
| 37 | WNK1 | 1.09418275 |
| 38 | MAP3K14 | 1.06895566 |
| 39 | JAK1 | 1.05374008 |
| 40 | GRK6 | 1.04623497 |
| 41 | MAP2K3 | 1.04459494 |
| 42 | AKT3 | 1.01069291 |
| 43 | ERBB2 | 0.98126617 |
| 44 | MAPK4 | 0.96529939 |
| 45 | MAP3K10 | 0.93667800 |
| 46 | STK38L | 0.92075723 |
| 47 | PRKCZ | 0.91730469 |
| 48 | BLK | 0.88825547 |
| 49 | SMG1 | 0.88544111 |
| 50 | ZAP70 | 0.85860440 |
| 51 | MAP3K11 | 0.85542024 |
| 52 | CDK6 | 0.85404004 |
| 53 | EPHB1 | 0.84885501 |
| 54 | KSR2 | 0.84334532 |
| 55 | DDR2 | 0.84129012 |
| 56 | MATK | 0.82273472 |
| 57 | MAPK15 | 0.81114677 |
| 58 | MET | 0.81030637 |
| 59 | CDC42BPA | 0.80639457 |
| 60 | MAP3K3 | 0.79994149 |
| 61 | MAPK12 | 0.79146773 |
| 62 | EPHA3 | 0.77632779 |
| 63 | PRKACG | 0.75392688 |
| 64 | PRPF4B | 0.74965380 |
| 65 | EEF2K | 0.74962749 |
| 66 | CSK | 0.74374528 |
| 67 | TIE1 | 0.74221312 |
| 68 | RIPK4 | 0.74166060 |
| 69 | NTRK3 | 0.73955771 |
| 70 | DYRK1B | 0.73886640 |
| 71 | CAMK2G | 0.70827137 |
| 72 | IRAK3 | 0.67641695 |
| 73 | EIF2AK1 | 0.67454891 |
| 74 | MAP2K6 | 0.64979082 |
| 75 | CAMK1D | 0.64596073 |
| 76 | GSK3A | 0.64139474 |
| 77 | SGK1 | 0.63654543 |
| 78 | PRKAA1 | 0.63636593 |
| 79 | CDK7 | 0.62971841 |
| 80 | RIPK1 | 0.61581362 |
| 81 | IKBKE | 0.59547999 |
| 82 | CSF1R | 0.59018163 |
| 83 | SGK3 | 0.58698399 |
| 84 | MAP4K1 | 0.57996352 |
| 85 | TGFBR2 | 0.56186168 |
| 86 | FGFR3 | 0.54651421 |
| 87 | MAPK7 | 0.54517983 |
| 88 | PTK2 | 0.52834370 |
| 89 | PDPK1 | 0.52784699 |
| 90 | PRKCQ | 0.50937102 |
| 91 | MAP3K5 | 0.50454716 |
| 92 | MAP3K13 | 0.49225017 |
| 93 | CSNK1G1 | 0.48479765 |
| 94 | TAOK2 | 0.47948060 |
| 95 | MAP3K6 | 0.47707594 |
| 96 | EPHA4 | 0.46637858 |
| 97 | RPS6KB1 | 0.46055878 |
| 98 | MARK2 | 0.45381808 |
| 99 | CSNK1E | 0.45065358 |
| 100 | IGF1R | 0.43687772 |
| 101 | PBK | 0.42478092 |
| 102 | CDK4 | 0.42393053 |
| 103 | MAP2K1 | 0.42079041 |
| 104 | CAMKK2 | 0.41491001 |
| 105 | GRK1 | 0.41107183 |
| 106 | RET | 0.41089457 |
| 107 | SGK2 | 0.40451742 |
| 108 | YES1 | 0.40448486 |
| 109 | SRC | 0.39926303 |
| 110 | SYK | 0.39762318 |
| 111 | PRKCG | 0.38879363 |
| 112 | MAPKAPK3 | 0.37742395 |
| 113 | LCK | 0.37473558 |
| 114 | TAOK1 | 0.36465261 |
| 115 | PKN1 | 0.36068519 |
| 116 | PRKG1 | 0.35567631 |
| 117 | ICK | 0.35540979 |
| 118 | EGFR | 0.34626348 |
| 119 | LATS2 | 0.34119850 |
| 120 | MTOR | 0.33728430 |
| 121 | CSNK1D | 0.33630273 |
| 122 | ITK | 0.32839821 |
| 123 | TNK2 | 0.32705130 |
| 124 | PDK1 | 0.32468024 |
| 125 | LYN | 0.29972939 |
| 126 | CAMK4 | 0.29835362 |
| 127 | FYN | 0.28424507 |
| 128 | CSNK1G2 | 0.27913500 |
| 129 | MAP3K1 | 0.26894427 |
| 130 | CSNK1G3 | 0.26318723 |
| 131 | IRAK1 | 0.25886254 |
| 132 | SGK494 | 0.25793083 |
| 133 | SGK223 | 0.25793083 |
| 134 | PRKCA | 0.25493715 |
| 135 | IRAK2 | 0.25213012 |
| 136 | PIK3CA | 0.23642524 |
| 137 | ABL1 | 0.23611770 |
| 138 | BMX | 0.19964078 |
| 139 | MAP2K2 | 0.19169602 |
| 140 | STK3 | 0.18487586 |
| 141 | MAPK3 | 0.18338655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56682858 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54774415 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40678339 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37110339 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08434250 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81295567 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69611982 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67259616 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62471543 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55774159 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45519387 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36725648 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25686126 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.17903970 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12556917 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07168117 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98884498 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96700296 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94510510 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91531249 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89415712 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85775974 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81308279 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79032797 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77197839 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76690783 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74445548 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72097490 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70222375 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66212493 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58585177 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57201694 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56930375 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50623074 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49706932 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48558515 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45001203 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33588814 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32853028 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32347563 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30446115 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27555958 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24021148 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20777245 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19565884 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.19426867 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17617438 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17070311 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10632238 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01306941 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00892396 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00503314 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98389874 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97302788 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96816260 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95374077 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87422139 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85167888 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80587051 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.79525278 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76533051 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69068193 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66343406 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65657914 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56950951 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50769093 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45987545 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45485787 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43679053 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.37601025 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25581300 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25415222 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23698869 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22535892 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22426335 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21174713 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19223047 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18036428 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15833115 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.10525900 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08010125 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05346842 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00985445 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2417219 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2410759 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2410040 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2348277 |
| 88 | Pertussis_Homo sapiens_hsa05133 | -0.2340540 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | -0.2296069 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2045747 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1897591 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1857637 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1810905 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1768943 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1624062 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1620634 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1605250 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.1573094 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.1567420 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1541578 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1449415 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1256703 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1154787 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1104212 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1084453 |
| 106 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0684217 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0681624 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0631524 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0439396 |
| 110 | Lysosome_Homo sapiens_hsa04142 | -0.0210619 |

